Search results
3 S&P 500 Stocks That Have Proven Themselves Recession-Proof
InvestorPlace via Yahoo Finance· 6 days agoSince 1928, there have been 25 bear markets, or declines in the S&P 500 of 20% or more, according to...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoNEW YORK, May 25, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between (Nasdaq: CERE) Cerevel Therapeutics Holdings, Inc. and AbbVie ...
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...
Morningstar· 3 days agoFN Media Group News Commentary - The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the prevention, diagnosis, and treatment of pancreatic ...
Senators Mull Ways to Stop Patent 'Abuse' by Pharma Companies
MedPage Today· 6 days ago"Too often the prices charged by Big Pharma do not reflect a scientific advancement," argued Sen....
IV Thrombolysis Offers No Benefit for Mild Stroke
Medscape· 5 days agoMinor ischemic stroke patients with intracranial occlusion should not be treated with IV thrombolysis, a new trial has concluded. Results from the...
3 Biotech Stocks to Buy on the Dip: May 2024
InvestorPlace· 3 days agoDespite their exciting growth potential and undeniable rewards, investors have been selling these stocks, causing a slight dip in price. Pfizer (NYSE:PFE) is a giant in biopharma, offering unique ...
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 5 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
8 Health Care Stocks Whale Activity In Today's Session - Abbott Laboratories (NYSE:ABT), AbbVie...
Benzinga· 3 days agoLoading... Loading... This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga ...
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
Zacks· 3 days agoAstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...
Benzinga· 2 days agoU.S. drug wholesaler Cencora Inc COR, formerly AmerisourceBergen, is notifying affected individuals...